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Retroviruses use unspliced RNA as mRNA for expression of virion structural proteins and as genomic RNA; the full-length
RNA often constitutes the majority of the viral RNA in an infected cell. Maintenance of this large pool of unspliced RNA is
crucial since even a modest increase in splicing efficiency can lead to impaired replication. In Rous sarcoma virus, the
negative regulator of splicing (NRS) was identified as a cis element that negatively impacts splicing of viral RNA. Components
of the splicing apparatus appear to be involved in splicing inhibition since binding of a number of splicing factors (snRNPs
and SR proteins) and assembly of a large complex (NRS-C) in nuclear extracts correlate with NRS-mediated splicing
inhibition. In determining the requirements for NRS complex assembly, we show that NRS-C assembly can be reconstituted
by addition of total SR proteins to an S100 extract that lacks these factors. Of the purified SR proteins tested, SF2/ASF was
functional in NRS-C assembly, whereas SC35 and SRp40 were not. The participation of snRNPs in NRS-C assembly was
addressed by selectively depleting individual snRNPs with oligonucleotides and RNase H or by sequestering critical snRNA
domains with 29-O-methyl RNA oligonucleotides. The results indicate that in addition to U11 snRNP, U1 snRNP and SR
proteins, but not U2 snRNP, are involved in NRS-C assembly. © 1998 Academic Press
INTRODUCTION
While most cellular RNAs are spliced to completion,
retrovirus replication requires that a substantial portion
of the primary transcripts remain unspliced to act as
gag-pol mRNA and as genomes for progeny virions (Cof-
fin, 1996). For example, in Rous sarcoma virus (RSV) only
;25% of the transcripts are spliced to subgenomic
RNAs. Because most retroviruses do not encode pro-
teins that influence RNA splicing, it is thought that splic-
ing control is exerted by elements in the viral RNA that
interact with cellular regulatory factors or components of
the splicing machinery. How this pool of unspliced RNA
is preserved is of interest since viruses modified to
oversplice are replication defective (Katz et al., 1988;
Zhang and Stoltzfus, 1995).
Splicing of precursor mRNAs (pre-mRNA) takes place
in a macromolecular complex called the spliceosome
that assembles through the binding of small nuclear
ribonucleoprotein particles (snRNPs) and a large number
of non-snRNP protein factors. Assembly of the major
pathway spliceosome occurs in a stepwise process in-
volving U1, U2, U4/U6, and U5 snRNPs and members of
the SR protein family that are required at each step in the
assembly process (reviewed in Moore et al., 1993;
Kramer, 1996). The structure and function of the SR pro-
teins have been extensively studied (reviewed in Fu,
1995; Manley and Tacke, 1996). They are characterized
by an N-terminal RNA binding domain(s) and a C-termi-
nal region rich in arginine–serine (RS) dipeptide repeats
(the RS domain) involved in protein:protein interactions.
The earliest splicing complex, the E or commitment com-
plex, assembles in vitro in the absence of ATP through
the binding of U1 snRNP to the 59 splice site, U2AF to the
pyrimidine tract of the 39 splice site, and the action of one
or more SR proteins (Michaud and Reed, 1991; Reed,
1990; Staknis and Reed, 1994). Subsequently, the transi-
tion to the prespliceosomal A complex proceeds in an
ATP-dependent step with the binding of U2 snRNP to the
branch point sequence. Entry of U4/U6 and U5 as a
tri-snRNP, again aided by SR proteins (Roscigno and
Garcia-Blanco, 1995), results in the mature spliceosome
(B complex) which is converted to its active form (C
complex) after a conformational rearrangement (Kramer,
1996). Thus, SR proteins appear to participate in a myriad
of protein:protein and protein:RNA interactions that are
necessary to define splice sites and assemble the
spliceosome.
A minor class of introns (AT-AC introns) containing
noncanonical splice sites and branch point sequence
(Hall and Padgett, 1994; Jackson, 1991) are removed in a
reaction mechanistically similar to the major splicing
pathway but employing distinct factors (reviewed in Tarn
and Stietz, 1997). These introns are flanked by AT and AC
at the 59 and 39 ends of the intron (rather than GT-AG)
and contain highly conserved consensus sequences at
the 59 splice site and branchpoint, but lack a polypyrimi-
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dine tract near the 39 splice site that is characteristic of
the major class of introns. In the minor spliceosome, U11
snRNP supplants U1 snRNP in binding the 59 splice site
(Kolossova and Padgett, 1997) and U12 snRNP replaces
U2 snRNP for branch point binding (Hall and Padgett,
1996; Tarn and Steitz, 1996). In addition, two newly dis-
covered snRNPs, U4atac and U6atac, replace U4 and U6
snRNPs in the minor spliceosome. Interestingly, U5
snRNP is common to both the major and minor spliceo-
somes. As in the major pathway, the minor spliceosome
assembles in a stepwise process. Splicing proceeds
through a lariat intermediate (Tarn and Steitz, 1996) and
likely involves a number of dynamic snRNA–snRNA and
snRNA–substrate interactions, as has been determined
for conventional introns (reviewed in Nilsen, 1996). Al-
though the snRNPs necessary for AT-AC splicing have
been delineated, other factors required for splicing minor
introns remain to be identified and it is not known if, like
U5 snRNP, other major pathway factors are also utilized
by the AT-AC spliceosome.
A number of negative cis elements in retroviral RNA
that contribute to the balance between unspliced and
spliced RNA have been identified in the last few years.
One of these, termed the negative regulator of splicing or
NRS, plays a repressive role in RSV splicing and is
located in the gag region ;300 nt downstream from the
59 splice site but over 4600 nt from the env 39 splice site
(Arrigo and Beemon, 1988; McNally et al., 1991). Viruses
harboring deletions in the NRS exhibited oversplicing to
both env and src, indicating that the NRS could control
splicing when located several thousand bases from the
nearest 39 splice site (Arrigo and Beemon, 1988; Stoltzfus
and Fogarty, 1989). In addition to repressing viral RNA
splicing, the NRS inhibits splicing of heterologous in-
trons in vivo and in vitro, but only when placed within the
intron (Gontarek et al., 1993; McNally et al., 1991). Local-
ization studies showed that the minimal NRS is ;230 nt
long and contains two important subregions, a purine-
rich region in the 59 half and a sequence in the 39 half
that matches the minor class 59 splice site consensus at
seven of eight positions (GTATCCTT vs ATATCCTT) (Gon-
tarek et al., 1993; McNally and McNally, 1996). The 39 half
also contains a branch point-like sequence followed by a
long pyrimidine tract, reminiscent of major pathway 39
splice sites. Partial matches (five of eight positions) to
the 59 splice site consensus are found in each half. Both
halves of the NRS are required for splicing inhibition and
are completely nonfunctional in isolation. The 59 region
was shown to bind SR proteins in vitro (primarily SF2/
ASF) and of particular significance was the observation
that in vitro binding of SF2/ASF correlates with inhibitory
activity in vivo (McNally and McNally, 1996). The NRS
also binds U11 snRNP; mutations in the predicted AT-AC
59 splice site that abolish U11 snRNP binding in vitro
severely impact splicing inhibition in vivo. In addition to
U11 snRNP, the NRS also binds U1 and U2 snRNPs
(Gontarek et al., 1993). However, deletion of the branch
point/pyrimidine tract region to which U2 snRNP presum-
ably binds has little effect on splicing inhibition. Like-
wise, no effect has been observed when the 59 splice
site-like sequences are mutated, and splicing has never
been observed from the NRS. Thus, the significance of in
vitro U1 and U2 snRNP binding is still in question.
The observation that the NRS binds factors involved in
splicing, particularly those suspected of 59 splice site
selection, suggested that the NRS might itself assemble
a spliceosome-like complex in vitro. We recently showed
by gel filtration chromatography that formation of an RNP
particle on the isolated NRS element, termed the NRS
complex (NRS-C), correlates with splicing inhibition
(Cook and McNally, 1996). The assembly characteristics
of NRS-C paralleled that of a complex formed on an
isolated 59 splice site (E59), suggesting that the NRS-C
might represent an AT-AC E59 complex. A better under-
standing of how the NRS inhibits splicing would be
gained by identifying the factors required for NRS-C
assembly. Since snRNPs and SR proteins bind to func-
tionally important NRS sequences, we investigated their
role in NRS-C assembly. Here we show that the SR
protein SF2/ASF, but not SC35 nor SRp40, is needed for
assembly of and is found within the NRS complex. In
addition to U11 snRNP, the results indicate that NRS-C
assembly requires U1 snRNP but not U2 snRNP.
RESULTS
The suggestion that the NRS might form a spliceo-
some-like complex by associating with a number of
splicing factors was confirmed by gel filtration with the
identification of the NRS-C (Cook and McNally, 1996).
Although analysis of NRS mutants which fail to bind U11
snRNP and SR proteins suggested that these factors
were required for NRS-C assembly, their role in assembly
and presence in the complex were not directly ad-
dressed, nor was a possible role for U1 or U2 snRNP
(Cook and McNally, 1996). We initially sought to investi-
gate the protein and snRNP content of the NRS-C by
affinity selection of complexes followed by fractionation
of components by gel electrophoresis, an approach used
successfully to examine spliceosome complexes
(Michaud and Reed, 1991; Bennett et al., 1992). Biotiny-
lated, 32P-labeled NRS RNA was incubated in nuclear
extracts in the absence of ATP to allow NRS-C assembly,
complexes were resolved by Sephacryl S-500 gel filtra-
tion, and pooled fractions containing NRS-C were affinity
selected with streptavidin–agarose beads. However, re-
peated efforts to visualize NRS-C proteins and RNAs,
even from scaled-up assembly reactions, were unsuc-
cessful despite the fact that a significant amount of the
labeled NRS RNA was specifically selected (data not
shown).
One explanation for our negative results is that the
NRS complex was not stable to the selection procedure.
This was addressed by affinity selecting NRS complexes
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directly from nuclear extract followed by Northern blot-
ting to assess U11 snRNP binding, which is diagnostic
for the NRS. It was previously shown by affinity selection
that U11/U12 snRNPs associate with adenovirus pre-
mRNAs harboring the minimal NRS, but Gontarek et al.
(1993) did not examine U11/U12 snRNP binding to the
isolated NRS. Therefore, biotinylated, 32P-labeled RNAs
representing the minimal NRS, adenovirus pre-mRNA
(Ad), or adenovirus pre-mRNA containing the NRS in the
intron (Ad-NRS) were incubated in nuclear extract with
ATP and complexes were selected with streptavidin–
agarose beads; nonbiotinylated RNAs were used as con-
trols for nonspecific binding to the beads. After extensive
washing, RNA components specifically associated with
the NRS were identified by Northern blotting and hybrid-
ization with U11 and U12 snRNA probes. As expected,
U11 snRNP was specifically selected by the Ad-NRS
substrate (Fig. 1, lanes 8 and 9) but not with the Ad
pre-mRNA (lanes 12 and 13). In comparison to the Ad-
NRS substrate, however, the U11 signal was substan-
tially lower when the isolated NRS RNA was used (lanes
10 and 11). Thus, under these conditions, U11 snRNP
bound more efficiently to Ad-NRS RNA than to the iso-
lated NRS. It was possible that the requirements for
complex assembly differed for Ad-NRS and free NRS
RNAs. In fact, NRS-C is not observed by gel filtration
when reactions contain ATP (Cook and McNally, 1996).
To address this, affinity selections were repeated with
reactions lacking ATP but again, the U11 signal was
much lower with NRS RNA relative to Ad-NRS (Fig. 1,
compare lane 5 to lane 3). The failure to detect NRS-C
components by affinity selection of gel filtration fractions
and the inability to efficiently select U11 snRNP from
extract, despite the fact that specific complexes were
formed, is consistent with the disassembly of NRS-C
during the selection procedure which prevents us from
directly visualizing components of the NRS complex. To
circumvent this technical limitation, the requirement for
SR proteins in NRS-C assembly was investigated using
an S100 extract that is devoid of SR proteins. Likewise,
participation of U1 and U2 snRNPs was addressed by
inactivating individual snRNPs in nuclear extract by oli-
gonucleotide-targeted RNase H depletion or 29-O-methyl
oligonucleotide sequestration, as described below.
SF2/ASF is required for NRS-C assembly
A role for SR proteins in NRS-C assembly was ad-
dressed with an S100 extract that lacks these factors. It
has been shown that S100 extract fails to splice pre-
mRNA and that splicing can be reconstituted by adding
purified or recombinant SR proteins (Krainer et al., 1990;
Mayeda et al., 1993; Zahler et al., 1993), indicating that
S100 extract contains all the factors necessary for splic-
ing except SR proteins. Along these lines, we reasoned
that NRS-C assembly would be severely compromised in
S100 extract if SR proteins are required and that addition
of SR proteins would reconstitute assembly if additional
factors are also present in S100 extract. An amount of
radiolabeled NRS RNA determined to produce equal
levels of NRS-C and nonspecific complexes (H complex)
was incubated under NRS-C assembly conditions in nu-
clear extract or an equivalent amount (by protein) of S100
extract, and reaction mixtures were resolved by gel fil-
tration. As shown in Fig. 2, the NRS complex was ob-
served in nuclear extract but was completely absent
from S100 extract (Figs. 2A and 2B). The NRS complex
was not observed over a range of S100 extract concen-
trations up to 60% of the reaction volume (data not
shown). To determine if the lack of complex formation
with S100 extract was due to a lack of SR proteins, total
SR proteins purified from HeLa cells were added to S100
extract and complex assembly was assessed. NRS-C
assembly was not apparent with 0.8 mg of SR protein
(Fig. 2E) but a small peak was observed with 1.6 mg (Fig.
2F), and 2.5 mg protein yielded approximately as much
complex as seen in nuclear extract (Fig. 2G). These data
suggest that one or more members of the SR protein
family are required for NRS complex assembly and that
additional factors are also present in S100 extract.
It was possible that the complementing activity was
not an SR protein but a minor contaminant in the SR
protein preparation. SR proteins were prepared by a
sequential two-salt precipitation procedure, the second
step being precipitation with MgCl2 (Zahler et al., 1992).
We reasoned that such a contaminant might be enriched
in the MgCl2 supernatant from the precipitation step.
Therefore, S100 extract was supplemented with 2.5 mg of
SR protein or an equivalent amount of protein from the
supernatant of the MgCl2 precipitation. In support of the
conclusion that SR proteins rather than a contaminant
were reconstituting NRS complex formation, only the
nonspecific H complex was observed with the MgCl2
supernatant (Fig. 2C). The possibility that SR proteins
FIG. 1. Inefficient affinity selection of NRS-C. Biotinylated and nonbi-
otinylated (indicated by 1/2) 32P-labeled Ad-NRS, NRS, and Ad RNAs,
as indicated, were incubated for 30 min under splicing conditions in
nuclear extract (25 ml) in the absence ([2] lanes 2–7) or the presence
([1] lanes 8–13) of ATP. The 2ATP reactions also lacked creatine
phosphate and MgCl2. The KCl concentration was then adjusted to 300
mM and RNAs were affinity selected with streptavidin–agarose beads.
After extensive washing at 300 mM KCl, material bound to the selected
RNAs was eluted and snRNAs were identified by Northern blotting with
U11 and U12 snRNA probes. U11 and U12 snRNA extracted from
nuclear extract served as markers (lane 1).
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alone were responsible for NRS-C was discounted by
incubating NRS RNA with SR proteins in the absence of
S100 extract; only a single peak was observed which
eluted in fractions corresponding to the H complex (Fig.
2D). This indicated that in addition to SR proteins another
factor(s) in S100 extract is required for NRS-C assembly.
Finally, when nonspecific RNA derived from pGEM-3Z
vector sequences was incubated in S100 extract, with SR
proteins alone, or in S100 extract supplemented with SR
proteins, only the H complex was observed (data not
shown), showing that the complex formed on NRS RNA
in S100 extract is specific.
When total SR proteins were tested for NRS binding
by UV cross-linking, SF2/ASF cross-linked strongly,
whereas SRp20 and SRp40 cross-linked more weakly
(McNally and McNally, 1996). To determine if SF2/ASF
was responsible for reconstituting NRS-C assembly in
S100 extract, baculovirus-expressed SF2/ASF was tested
in the assembly assay. S100 extract supplemented with
1.1 mg SF2/ASF produced a NRS-C level similar to that
achieved with 1.6 mg of total SR proteins (Fig. 3B, com-
pare with Fig. 2F). Thus, SF2/ASF alone is capable of
reconstituting NRS complex assembly in S100 extract.
Another SR protein, SC35, has the same mobility as
SF2/ASF in SDS–PAGE and conceivably, some of the
cross-linking signal observed with nuclear extract could
be due to SC35, even though purified SC35 binds the
NRS very weakly and nonspecifically (McNally and Mc-
Nally, 1996). This was tested in the complementation
assay with baculovirus-expressed SC35. Also tested was
SRp40, which in nuclear extract shows low but specific
cross-linking to the NRS. In contrast to SF2/ASF, addition
to S100 extract of up to 2.25 mg SC35 (Fig. 3C) or 3 mg
SRp40 (Fig. 3D) failed to support NRS-C formation. These
results demonstrate that SR proteins do not have over-
lapping activities in NRS complex assembly. From these
experiments, we conclude that SF2/ASF is required for
FIG. 2. SR proteins are required for NRS-C assembly. NRS RNA was incubated for 20 min under assembly conditions in nuclear extract (A) or an
equivalent amount of S100 extract protein (B), and samples were fractionated by gel filtration on Sephacryl S500 columns. Reactions lacked ATP,
creatine phosphate, and MgCl2. In addition, S100 extract was supplemented with 0.8 mg (E), 1.6 mg (F), or 2.5 mg (G) of total SR proteins purified from
HeLa cells and NRS complex assembly was assessed. Control reactions contained S100 extract supplemented with the MgCl2 supernatant (C) or
total SR proteins alone (D). Peaks representing the NRS complex and the nonspecific H complex are indicated. The peak eluting between fractions
65 and 75 contains degraded RNA (the void volume was not collected).
FIG. 3. Recombinant SF2/ASF, but not SC35 or SRp40, reconstitutes
NRS-C assembly. Radiolabeled NRS RNA was incubated under assem-
bly conditions (100 ml) in S100 extract alone (A) or S100 extract sup-
plemented with baculovirus-expressed SF2/ASF (1.1 mg) (B), SC35 (2.2
mg) (C), or SRp40 (3 mg) (D). Reactions lacked ATP, creatine phosphate,
and MgCl2. Samples were then applied to gel filtration columns. The
NRS and H complexes are indicated. Peaks between 30 and 35 and 65
and 75 contain the void volume and total volume, respectively.
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NRS-C assembly, although we cannot discount a role for
other SR proteins.
SF2/ASF is a component of the NRS complex
Since the NRS-C was not stable to affinity selection,
we performed UV cross-linking to identify proteins inti-
mately associated with NRS RNA in gel filtration fractions
containing NRS-C. Complexes were assembled in nu-
clear extract on 32P-labeled NRS RNA and proteins in
contact with the RNA were covalently attached by UV
cross-linking. After resolution by gel filtration, three frac-
tions from the NRS or H complex peaks were pooled and
treated with RNase A to remove most of the RNA, and the
concentrated sample was subjected to electrophoresis
in a 12% SDS gel followed by autoradiography to identify
labeled proteins. As reported previously (McNally and
McNally, 1996), the pattern generated with total SR pro-
teins revealed SRp30 (SF2/ASF) as the major cross-
linked species, with low levels of SRp20, SRp40, and
SRp55 also detectable (Fig. 4, lane 1). A strikingly similar
pattern was obtained from the cross-linked NRS com-
plex, except that the band corresponding to SRp55 was
not apparent (Fig. 4, lane 2). In contrast, the nonspecific
H complex formed on the NRS produced a different and
more complex pattern, and the proteins seen in the NRS
complex were largely excluded from the H complex and
vice versa (Fig. 4, compare lanes 2 and 3). The H com-
plex assembled on RNA derived from pGEM vector se-
quences was also examined and the protein pattern
resembled that seen with the NRS H complex; no SR
protein cross-linking was detected (Fig. 4, lane 4). In
other experiments, cross-linking was performed on the
column fractions rather than in the nuclear extract before
gel filtration. The results were essentially the same ex-
cept that the band intensities were much lower (data not
shown). Thus, with NRS RNA a similar panel of cross-
linked proteins was observed with total SR proteins and
the NRS complex, showing that SR proteins are not only
required for NRS-C assembly but are components of the
complex. Again, as in nuclear extract, SRp30 (presum-
ably SF2/ASF) was the major cross-linked species in the
NRS complex.
snRNP requirement for NRS-C assembly
In addition to SR proteins, U1, U2, U11, and U12
snRNPs bind the NRS in vitro, and binding of U11 snRNP
correlates with in vivo splicing inhibition (Gontarek et al.,
1993). This suggested that U11 snRNP and perhaps the
other snRNPs may be involved in NRS-C assembly. Since
it was not possible to examine NRS-C directly, a snRNP
requirement for NRS-C formation was initially addressed
using nuclear extracts treated with micrococcal nucle-
ase (MN), which degrades single-stranded nucleic acid
and destroys snRNPs. The NRS complex was not ob-
served in extracts treated with a high concentration of
MN (4000 U/ml) (Fig. 5C), while assembly was decreased
by about 50% when 200 U/ml MN was used (Fig. 5B; note
that loss of the NRS complex results in a corresponding
increase in H complex). The reduction in assembly ac-
tivity was due to the nuclease activity of MN since the
amount of NRS-C generated in extract treated with EGTA
prior to MN addition (to inactivate the MN) was un-
changed relative to untreated extract (compare Figs. 5A
and 5D). This observation supported the proposed role of
an RNA containing component in NRS-C assembly, as
would be expected for a snRNP. It was found upon
inspection of the snRNP composition of treated extracts
by Northern blot analysis that all of the splicing snRNPs
(U1, U2, U4, U5, U6, U11, and U12 snRNPs) were de-
graded by 4000 U/ml MN, but a significant level of U1
and U11 remained after the mild treatment (Fig. 5E; U4/6
and U5 data not shown). Both concentrations of MN
inhibited splicing of an adenovirus pre-mRNA (data not
shown). The finding that some NRS-C assembly occurred
in extracts treated with low levels of MN implicated U1
and/or U11 in the NRS-C assembly process.
In an effort to determine which snRNPs were important
for NRS-C assembly, a targeted depletion strategy was
employed whereby individual snRNPs were inactivated
by treating extract with snRNA-specific oligonucleotides
and RNase H to degrade essential snRNA domains. U1
and U2 snRNPs were inactivated with oligonucleotides
complementary to U1 snRNA bases 1–14 (U11–14) and U2
snRNA bases 27–49 (U227–49), the sequences required
FIG. 4. SF2/ASF is a component of NRS-C. Radiolabeled NRS RNA or
transcribed pGEM vector sequences were incubated for 20 min in
nuclear extract, irradiated with 254-nm light for 15 min, and then
applied to gel filtration columns. Three fractions constituting the NRS or
H complex peaks were pooled and treated with RNase A, and the
proteins were subjected to 12% SDS–PAGE followed by autoradiogra-
phy. Lane 1, total SR proteins cross-linked to NRS RNA. Lanes 2 and 3,
nuclear extract proteins cross-linked to NRS RNA in gel filtration frac-
tions containing the NRS and H complexes. Lane 4, proteins cross-
linked to pGEM RNA in the H complex (pGEM RNA forms only the
nonspecific H complex). The migration of molecular weight markers
and cross-linked SRp20, SRp30, and SRp40 are indicated.
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by each for pre-mRNA binding (Black et al., 1985). As
shown in Fig. 6, NRS-C assembly was reduced by about
50% in extract treated with U11–14 compared with control
extracts (Figs. 6A and 6B), whereas no effect was seen
with U227–49 (Fig. 6D). It has been shown that the RNA
component of U11 snRNP is inaccessible to oligonucle-
otides (Wassarman and Steitz, 1992) and thus it was not
possible to directly examine the contribution of U11
snRNP to NRS-C assembly by targeted depletion. How-
ever, it was previously shown (Cook and McNally, 1996)
that the assembly activity of an NRS mutant that fails to
bind U11 snRNP was decreased by ;50%, indicating the
importance of U11 snRNP. The data here support a role
for U1 snRNP in NRS-C assembly and suggest that while
U2 snRNP binds to the NRS, it is not required for as-
sembly.
Extracts treated with U11–14 and U227–49 oligonucleo-
tides to degrade the snRNPs exhibited low but reproduc-
ible splicing activity, and it was found on denaturing gels
that a population of the snRNAs was resistant to cleav-
age, particularly so for U2 snRNA (data not shown). This
raised the possibility that the remaining NRS-C peak
seen in the depleted extracts was due to residual U1 or
U2 snRNP that had escaped cleavage. An alternative
snRNP inactivation method is to use 29-O-methyl RNA
oligonucleotides, which bind an RNA target with greater
affinity than DNA oligos, are not substrates for nucleases
and therefore can be more effective tools for snRNP
inactivation (Lamond et al., 1989). Splicing assays per-
formed with the U11–14 and U227–49 29-O-methyl RNA
oligonucleotides showed complete splicing inhibition
(data not shown), indicating complete functional inacti-
vation of U1 and U2 snRNPs. The splicing block was
specific since a 29-O-methyl oligonucleotide complemen-
FIG. 5. A micrococcal nuclease-sensitive factor is required for NRS-C assembly. NRS complex assembly was assessed by gel filtration with
untreated nuclear extract (A), extract treated with 200 U/ml (B) or 4000 U/ml (C) micrococcal nuclease (MN), or a control MN reaction in which EGTA
was added to the extract prior to MN to inactivate the enzyme (D). (E) Northern blot of snRNAs from MN-treated extracts. snRNAs obtained by phenol
extraction of the extracts used in A–D were run on a denaturing 8 M urea–8% polyacrylamide gel, the snRNAs were transferred to a nylon membrane
and hybridized with U11 and U12 (top) or U1 and U2 (bottom) snRNA probes, and autoradiography was performed. The positions of the snRNAs are
indicated.
FIG. 6. Effect of targeted U1 and U2 snRNP depletion on NRS-C
assembly. The role of individual snRNPs in NRS-C assembly was
determined by cleaving essential snRNA domains with a complemen-
tary oligonucleotide and RNase H. Untreated control nuclear extract (A
and C) or extract pretreated with RNase H and an oligonucleotide
complementary to U1 nt 1–14 (B) or U2 nt 27–49 (D) were used in 100-ml
assembly reactions, and the samples were analyzed by gel filtration.
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tary to U7 snRNP, which is not involved in mRNA splicing,
had no effect on splicing (data not shown).
Nuclear extract incubated with the U11–14 29-O-methyl
oligonucleotide showed a ;threefold decrease in the
assembly of the NRS complex relative to an untreated
control but again, some NRS-C remained (Figs. 7A and
7B). No effect on the NRS-C level was observed when the
extract was treated with the U2 snRNA 29-O-methyl oli-
gonucleotide, although the amount of H complex de-
creased (Fig. 7C). The results obtained with the U1 29-
O-methyl oligonucleotide were specific since in addition
to U227–49, a 29-O-methyl oligo complementary to U7
snRNP (U73–20) had no effect on NRS-C assembly (Fig.
7D). Thus, the U11–14 results were due to a specific
interaction between the snRNA and the RNA oligonucle-
otide and not to nonspecific effects of adding the oligo-
nucleotides to the extract. The results of the targeted
disruption experiments demonstrate that in addition to
U11 snRNP (Cook and McNally, 1996), U1 snRNP also
contributes to NRS-C assembly. The observation that
NRS-C assembly was not completely abolished with the
U11 snRNP binding mutant (Cook and McNally, 1996) or
in U1-oligonucleotide-treated extracts indicates that
NRS-C can form in the absence of one or the other
snRNPs, albeit at reduced efficiency. Alternatively, the
NRS-C peak may not be homogenous but rather com-
posed of two separate complexes, one dependent on U1
and the other on U11.
DISCUSSION
Retroviral replication requires inefficient splicing to
preserve a large pool of unspliced RNA that serves as
mRNA and genome for progeny virions (Coffin, 1996).
While the maintenance of suboptimal 39 splice sites in
RSV and HIV has been shown to be one mechanism of
splicing control (Dyhr-Mikkelsen and Kjems, 1995; Fu et
al., 1991; McNally and Beemon, 1992; O’Reilly et al., 1995;
Staffa and Cochrane, 1994; Zhang et al., 1996; Zhang and
Stoltzfus, 1995), RSV harbors an additional control ele-
ment, the NRS, which binds components of the splicing
machinery including SR proteins and U1 and U2 snRNPs.
Particularly intriguing are data indicating the involvement
of a minor pathway splicing factor, U11 snRNP, in NRS-
mediated splicing inhibition. We recently detected by gel
filtration an RNP complex that forms on the NRS whose
assembly correlates with splicing inhibition activity. In
this study, we wished to investigate the participation of
the NRS binding factors in assembly of NRS-C. The data
support a role for SF2/ASF, U1, and U11 snRNPs, but not
U2 snRNP, in NRS complex assembly.
Previous work showed that SR proteins can cross-link
to an essential purine-rich region in NRS RNA, with
SF2/ASF cross-linking strongly relative to SRp40 (Mc-
Nally and McNally, 1996). This suggested that SF2/ASF
plays a predominant role in NRS-mediated splicing inhi-
bition. We found that total SR proteins, and specifically
SF2/ASF but not SC35 or SRp40, could reconstitute
NRS-C assembly, suggesting that SR proteins do not
have overlapping functions in this assay. SR proteins
exhibit overlapping activities in complementing a splic-
ing-deficient S100 extract (Fu et al., 1992; Kim et al., 1992;
Mayeda et al., 1992; Zahler et al., 1992), but they also
display distinct activities in committing different pre-
mRNAs to splicing (Fu, 1993) and different binding spec-
ificities (Tacke and Manley, 1995). For example, SC35
commits b-globin pre-mRNA to splicing more efficiently
than SF2/ASF, whereas SF2/ASF, but not SC35, commits
HIV tat pre-mRNA to splicing (Fu, 1993). The different
biochemical activities probably reflect distinct binding
specificities of the proteins. In fact, SF2/ASF and SC35
selected different sequences in a reiterative in vitro se-
lection procedure (SELEX) to identify optimal binding
sites (Tacke and Manley, 1995). One explanation of why
SRp40 did not support NRS-C assembly may be that the
NRS lacks a high-affinity binding site. Recently, the opti-
mal SRp40 binding sequence was determined to be ;18
nt, with two potential half sites (Tacke et al., 1997). The
NRS does not harbor a consensus site but it does have
sequences that resemble the first 7 nt of the consensus,
one of which is in an important part of the purine-rich
region. The binding affinity of the half sites has not been
determined, and it is not known if SRp40 binds this
sequence in the NRS. Another possibility for the failure of
SRp40 to complement NRS-C assembly is that the RS
domains of SRp40 and SF2/ASF are not interchangeable.
We consider this less likely since the RS domains of
SF2/ASF and SC35 were shown to be interchangeable
for splicing ß-globin and tat pre-mRNAs (Chandler et al.,
1997), and the RS domains of SRp40, SC35, and X16 were
FIG. 7. Effect of 29-O-methyl oligonucleotide inactivation of U1 and U2
snRNPs on NRS-C assembly. Untreated nuclear extract (A) or extract
pretreated with 29-O-methyl oligonucleotides complementary to U1 nt
1–14 (B), U2 nt 27–49 (C), or U7 nts 3–20 (D) were used in 100-ml
assembly reactions and complexes were analyzed by gel filtration.
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functional when fused to the SF2/ASF RNA binding do-
main (J. Manley, personal communication). Thus, the abil-
ity of only SF2/ASF to participate in NRS-C assembly is
probably due to a high-affinity binding site(s) within the
NRS, as suggested previously (McNally and McNally,
1996).
Staknis and Reed (1994) found that SR proteins UV
cross-link to pre-mRNAs and splicing enhancer se-
quences in E59, E39, and enhancer complexes but not in
H complexes. Our data show that SF2/ASF was present
in NRS-C but not in the H complex, indicating that it
remains with the NRS RNA after assembly. That SF2/ASF
binds to the critical purine-rich region in the 59 half of the
NRS and is a specific component of NRS-C suggests that
SF2/ASF binding is functionally significant. The RS do-
main of SF2/ASF interacts with a similar motif in the 70K
protein component of U1 snRNP, and this interaction is
required for cooperative binding of U1 snRNP to 59 splice
sites (Kohtz et al., 1994). Perhaps a similar interaction
between SF2/ASF and a 70K-like protein in U11 snRNP
assists U11 snRNP binding to the NRS.
Apart from the fact that U1 and U2 snRNPs bind the
NRS in vitro (Gontarek et al., 1993), evidence supporting
their role in NRS function is lacking. Results presented
here indicate that U2 snRNP does not play a role in
NRS-C formation, since U2-inactivated extracts assem-
bled NRS-C normally. Thus, it is unlikely that U2 snRNP is
involved in splicing inhibition in vivo. The probable NRS
binding site for U2 snRNP is a branch point-like region
followed by a pyrimidine tract (McNally et al., 1991), but
deletion of this region does not abolish NRS activity,
further suggesting that U2 snRNP binding is not relevant
to function. It is possible that U2 snRNP binds the NRS
indirectly via U1 snRNP, which was suggested as a
possibility for the presence of U2 snRNP in the spliceo-
somal E complex (Hong et al., 1997). Alternatively, U2
snRNP may be interacting with U11 snRNP. Regardless
of the mechanism of association with the NRS, the data
to date do not support a role for U2 snRNP in NRS
function. Unlike the results with U2 snRNP, extracts in
which U1 snRNP was debilitated were impaired for NRS
complex assembly, which may reflect some biological
relevance. However, given that mutation or deletion of
several candidate U1 binding sites in the NRS has no
effect on splicing inhibition, another possibility is that the
U1 snRNP binding observed in vitro is a consequence of
its high abundance and the presence of SR protein
binding sites in the NRS. The SR proteins may artifactu-
ally recruit U1 snRNP to the NRS in vitro in a manner
which is unrelated to a functional role in splicing inhibi-
tion. In contrast to U1 and U2 snRNPs, there is strong
evidence that U11 snRNP binding is important for NRS
function (Gontarek et al., 1993). Furthermore, using chi-
meric substrates we have recently detected splicing
from the NRS to a U12-dependent 39 splice site (unpub-
lished data), indicating that U11 snRNP binding to the
NRS is functional in this artificial context. Splicing has
never been detected to U1- or U2-dependent splice sites
in similar constructs. Therefore, the observed involve-
ment of U11 snRNP in NRS-C assembly likely reflects its
requirement for splicing inhibition.
The observation that the NRS complex persists to a
degree in U1 snRNP debilitated extracts and on sub-
strates incapable of binding U11 snRNP suggest that
NRS-C may be a mixture of at least two different types of
complexes. Were both snRNPs required for assembly,
one would expect a complete loss of NRS-C when one or
the other snRNP was inactivated. As NRS-C is observed
only in the absence of ATP, it is possible that it resembles
complexes that form on isolated 59 splice sites (E59
complex) of the major and minor pathways, dependent
upon U1 and U11 snRNP, respectively. The complex as-
sembled on the U11 snRNP binding mutant would rep-
resent the U1-dependent E59 complex, and the peak
remaining in U1-depleted extracts might be an AT-AC
type E59 complex. This possibility remains unresolved
but if true, we estimate that approximately one-half to
two-thirds of the peak is represented by the U1-depen-
dent complex. AT-AC splicing complexes have not been
examined by gel filtration. A more direct comparison of
NRS-C to authentic minor class splicing complexes
might be informative, and we are currently examining the
possible relationship between such complexes and
NRS-C in hopes of resolving this issue.
MATERIALS AND METHODS
DNA constructs and in vitro transcription
Transcription from plasmids pAdHS and p3ZBB to gen-
erate an adenovirus in vitro splicing substrate and the
minimal NRS RNA (NRS nt 703 to 930), respectively,
was described previously (Cook and McNally, 1996).
pAdKX-BB was generated by inserting an NRS PCR frag-
ment containing RSV nucleotides 701 to 932 into the
BstEII intron site of pAdHS (KpnI and XbaI sites were
appended to the ends of the PCR product). RNA was
produced in vitro with T7 RNA polymerase and EcoRI cut
DNA as described (Cook and McNally, 1996). In vitro
transcription of biotinylated RNA and affinity selection
experiments were as previously described (Gontarek et
al., 1993) except that biotin-11–UTP constituted 30% of
the total UTP. Nuclear and S100 extracts were prepared
by standard methods except that buffer D contained 20
mM Tris–HCl rather than HEPES (Dignam et al., 1983).
Total HeLa cell SR proteins were prepared exactly as
described (Zahler et al., 1992). Baculovirus-expressed
ASF/SF2 was kindly provided by Adrian Krainer, while
SC35 and SRp40 were generous gifts of Xiang-Dong Fu.
Assembly reactions and gel filtration
Assembly reactions employed in vitro splicing condi-
tions (100 ml, 17 mM Tris–HCl, pH 7.8, 60 mM KCl, 20 mM
creatine phosphate, 0.4 mM ATP, 3 mM MgCl2) and
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contained 60% nuclear extract or an equivalent amount
of S100 extract protein, and 300 fmol of RNA. Reactions
performed in the absence of ATP also lacked MgCl2 and
creatine phosphate, and the nuclear extract was prein-
cubated for 20 min at room temperature to deplete any
endogenous ATP. For oligonucleotide-targeted RNase H
cleavage, oligonucleotides (40 mg/ml) complementary to
nt 1–14 of U1 snRNA (U11–14) or nt 27–49 of U2 snRNA
(U227–49) and 0.08 units/ml RNase H were incubated in
nuclear extract at 30°C for 30 min; the extract was then
used for in vitro binding assays as described above. To
assess the extent of cleavage, a sample of the extract
was also extracted with phenol and the snRNAs were
separated on a denaturing 8 M urea–8% polyacrylamide
gel, followed by Northern blot analysis. In experiments
with 29-O-methyl RNA oligonucleotides (synthesized by
John Flory, Yale University), nuclear extract was incu-
bated at 30°C for 20 min with 29-O-methyl oligos (30 mM
U11–14, 8 mM U227–49, 4 mM U73–20) and then used for
binding assays as described above. Gel filtration was
performed as described previously (Cook and McNally,
1996) at a flow rate of 6 ml/h. Samples were applied
directly onto a 1.5 3 50 cm Sephacryl S-500 column
equilibrated in FSP buffer (20 mM Tris–HCl, pH 7.8, 0.1%
Triton X-100, 60 mM KCl, 2.5 mM EDTA), 1-ml fractions
were collected, and 40 ml was counted in a Packard
microwell plate scintillation counter. Large-scale gel fil-
tration was performed as described by Bennett et al.
(1992). Due to variability among columns, the precise
fractions in which the different complexes elute can be
slightly different between experiments.
Affinity selection
Biotinylated or nonbiotinylated, 32P-labeled RNA (300
fmol) was incubated for 30 min at 30°C in a 25-ml reac-
tion mixture under splicing conditions or in the absence
of ATP, creatine phosphate, and MgCl2. Samples were
put on ice and an equal volume of SB buffer (10 mM
Tris–HCl, pH 7.8, 3 mM MgCl2, 1 mM DTT, 540 mM KCl)
was added to raise the KCl concentration to 300 mM. A
50:50 slurry of streptavidin–agarose beads (10 ml) was
added and mixed for 1 h at 4°C, followed by four washes
for 5 min each in NET-300 buffer (50 mM Tris–HCl, pH 7.8,
0.05% NP-40, 0.5 mM DTT, 300 mM KCl). Bound material
was released by incubating the beads for 15 min at 37°C
in 200 ml Proteinase K buffer (10 mM Tris–HCl, pH 7.8, 5
mM EDTA, 0.5% SDS) containing 0.5 mg/ml Proteinase K.
The eluted RNAs were then extracted with phenol, eth-
anol precipitated, subjected to electrophoresis in a de-
naturing 8 M urea–8% polyacrylamide gel, and trans-
ferred to a ZetaProbe GT (Bio-Rad) membrane. The blot
was hybridized overnight at 50–55°C with riboprobes to
U11 and U12 snRNAs as described (Gontarek et al.,
1993).
Micrococcal nuclease digestion
Nuclear extract was supplemented with CaCl2 (1 mM
final) and either 200 or 4000 units/ml MN and incubated
for 30 min at 30°C. The nuclease was then inactivated by
the addition of EGTA to 4 mM and the extract was used
for binding assays as described above. To assess the
extent of RNA degradation, a portion of the treated ex-
tract was extracted with phenol and the snRNAs were
separated on a denaturing 8 M urea–8% polyacrylamide
gel and Northern analysis was performed with ribo-
probes complementary to U11 and U12 snRNAs. Blots
were stripped with two 20-min washes in boiling 0.13
SSC–0.5% SDS and reprobed with U1, U2, U4, U5, and U6
snRNA riboprobes.
UV cross-linking
Binding reactions were spotted on parafilm, irradiated
with 254-nm light (UVP Model UVG-54) for 15 min at 4°C
at a distance of 5 cm, and then applied to gel filtration
columns. Alternatively, UV cross-linking was performed
after gel filtration using pooled fractions of the specific or
nonspecific peaks. Samples were incubated with 0.1
mg/ml RNase A for 30 min at 37°C, SDS and DTT were
added to 2% and 20 mM, respectively, and incubated for
5 min at 65°C, and the proteins were precipitated with
glycogen and 4 vol acetone. The proteins were resus-
pended in SDS sample buffer, separated by electro-
phoresis in a 12% SDS gel, and autoradiography was
performed.
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